Effetti avversi gastrointestinali (GI) Negli studi di fase 3, sia la semaglutide orale che quella sottocutanea sono state associate a disturbi gastrointestinali, come nausea, vomito e diarrea, effetti ben noti di questa classe di farmaci
This case study , published in 2023, describes three female patients taking semaglutide who visited their healthcare clinic due to severe mouth dryness, as well as minimal frothy saliva. After underlying medical problems were excluded (such as low water intake or a condition called Sjogrens disease) as the cause, the females were diagnosed with hyposalivation (dry mouth)
Any initial sensitivity (mild redness or tingling) typically resolves within days, not weeks
Occlusion of the Superior Mesenteric Artery in Rats Reversed by Collateral Pathways Activation: Gastric Pentadecapeptide BPC 157 Therapy Counteracts Multiple Organ Dysfunction Syndrome
Sermorelin stimulates the pituitary gland through GHRH receptors